Business
Passing of Genmab A/S’ Annual General Meeting
Company Announcement At Genmab A/S’ Annual General Meeting held today March 19, 2026, the Annual Report for 2025 was approvedDischarge was given to the Board of Directors and the Executive Management and the year’s profit was carried forwardThe 2025 Compensation Report was approvedSix members of the Board of Directors were re-electedDeloitte was re-elected as the auditor of the CompanyThe proposal from the Board of Directors to reduce the Company’s share capital with nominally DKK 1,900,000 by c
About this update from Genmab A/s
[{"type":"image","alt":"Genmab A/S","displaySize":"","headline":null,"caption":"Genmab A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":275,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/c0cd563151331363bc069dc3ced1531d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/AGO7EVEtSEHL6RvrRWW5kQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMA--/https://media.zenfs.com/en/globenewswire.com/c0cd563151331363bc069dc3ced1531d","width":275,"height":85}},"lazy":false},{"type":"text","content":"Company Announcement","length":20,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"At Genmab A/S’ Annual General Meeting held today March 19, 2026, the Annual Report for 2025 was approved","length":124,"tagName":"p"}]},{"val":[{"type":"text","content":"Discharge was given to the Board of Directors and the Executive Management and the year’s profit was carried forward","length":121,"tagName":"p"}]},{"val":[{"type":"text","content":"The 2025 Compensation Report was approved","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"Six members of the Board of Directors were re-elected","length":63,"tagName":"p"}]},{"val":[{"type":"text","content":"Deloitte was re-elected as the auditor of the Company","length":58,"tagName":"p"}]},{"val":[{"type":"text","content":"The proposal from the Board of Directors to reduce the Company’s share capital with nominally DKK 1,900,000 by cancellation of the Company's holding of shares was adopted","length":189,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":606,"olType":false},{"type":"text","content":"COPENHAGEN, Denmark; March 19, 2026 – Genmab A/S (Nasdaq: GMAB) held its Annual General Meeting, today at the Copenhagen Marriott Hotel, Copenhagen, Denmark. At the meeting, Deirdre P. Connelly, Chair of the Board of Directors gave – on behalf of the Board of Directors – a report on the Company’s activities during the past year. Chief Executive Officer Dr. Jan van de Winkel presented the Company’s plans for 2026, and Chief Financial Officer Mr. Anthony Pagano presented the Annual Report for 2025 endorsed by the auditors. The report was approved, and discharge was given to the Board of Directors and the Executive Management.It was decided that the year’s pro...